drugset / Trial / NCT02977507
Split-face Study Comparing the Cosmetic Efficacy and Tolerability of Two Topical Products in Participants With Moderate Facial Melasma
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to evaluate the efficacy and tolerability of Lytera 2.0 versus 4% hydroquinone in the improvement of the appearance of moderate facial melasma.
Timeline
- Start
- 2016-12-13
- Primary completion
- 2017-10-09
- Completion
- 2017-10-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydroquinone | Small molecule | 4 % | Topical |